Robyn T. Carson

Patient-Centered Outcomes Research Institute — United States

Medicine · Health Sciences

15h-index1.2kcitations101works0.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Gastrointestinal motility and disorders(76), Gastroesophageal reflux and treatments(18), Congenital gastrointestinal and neural anomalies(16), Intestinal Malrotation and Obstruction Disorders(7), Chronic Obstructive Pulmonary Disease (COPD) Research(4)

Publications101 total

From clinical trials to informing clinical decision-making: a review of patient-reported outcomes in nononcology medicines approved by the European Medicines Agency (2018–2022)
Frontiers in Pharmacology·2025Open Access
Leveraging sensor-based functional outcomes to enhance understanding of the patient experience: challenges and opportunities
Expert Review of Pharmacoeconomics & Outcomes Research·2024
Psychometric Evaluation of the Diary for Irritable Bowel Syndrome Symptoms-Constipation in a Prospective Observational Study
Value in Health·2024· 2 cited
Patient Experience Data for Medical Product Development: Opportunity Beyond Obligation
Patient·2022· 10 cited
A Review of Patient-Reported Outcome Labeling of FDA-Approved New Drugs (2016-2020): Counts, Categories, and Comprehensibility
Value in Health·2021· 45 citedOpen Access
coreNASH: Multi-stakeholder Consensus on Core Outcomes for Decision Making About Nonalcoholic Steatohepatitis Treatment
Hepatology Communications·2021· 6 citedOpen Access
Comprehensive assessment of patients with irritable bowel syndrome with constipation and chronic idiopathic constipation using deterministically linked administrative claims and patient-reported data: the Chronic Constipation and IBS-C Treatment and Outcomes Real-World Research Platform (CONTOR)
Journal of Medical Economics·2020· 15 citedOpen Access
Mo1521 DIARY FOR IRRITABLE BOWEL SYNDROME SYMPTOMS—CONSTIPATION: EVIDENCE TO SUPPORT A RESPONDER DEFINITION FOR THE ABDOMINAL SYMPTOM SCORE USING PHASE 3B CLINICAL TRIAL DATA
Gastroenterology·2020
Psychometric Analysis of the Abdominal Score From the Diary for Irritable Bowel Syndrome Symptoms–Constipation Using Phase IIb Clinical Trial Data
Value in Health·2020· 11 citedOpen Access
The Impact of Stool Consistency on Bowel Movement Satisfaction in Patients With IBS-C or CIC Treated With Linaclotide or Other Medications
Journal of Clinical Gastroenterology·2019· 5 citedOpen Access
Su1587 – New Patient Reported Outcome Measure: Diary for Irritable Bowel Syndrome Symptoms—Constipation, Guidelines for Interpretation of Change in Abdominal Symptoms Using Phase 2B Clinical Trial Data
Gastroenterology·2019Open Access
<p>Development and psychometric evaluation of the Diabetic Gastroparesis Symptom Severity Diary</p>
Clinical and Experimental Gastroenterology·2019· 8 citedOpen Access
PGI46 - PSYCHOMETRIC EVALUATION OF THE DIARY FOR IRRITABLE BOWEL SYNDROME SYMPTOMS-CONSTIPATION (DIBSS-C)
Value in Health·2018· 1 cited
The impact of treatment with eluxadoline on health-related quality of life among adult patients with irritable bowel syndrome with diarrhea
Quality of Life Research·2018· 11 citedOpen Access
Health Care Resource Use and Costs Pre- and Post-Treatment Initiation With Linaclotide: Retrospective Analyses of a U.S. Insured Population.
PubMed·2018· 2 cited
Impact of Stool Consistency on Bowel Movement Satisfaction in IBS-C or CIC Patients Treated With Linaclotide or Other Medications: Results From the CONTOR Study
The American Journal of Gastroenterology·2017
Development of a Symptom-Focused Patient-Reported Outcome Measure for Functional Dyspepsia: The Functional Dyspepsia Symptom Diary (FDSD)
The American Journal of Gastroenterology·2017· 29 citedOpen Access
Differences in Demographic and Symptom-Related Characteristics among Patients with Irritable Bowel Syndrome with Constipation (IBS-C) and Chronic Idiopathic Constipation (CIC): Results from the Contor Study
Gastroenterology·2017· 1 cited
Development and Psychometric Evaluation of the Diabetic Gastroparesis Symptom Severity Diary
Gastroenterology·2017· 6 cited
Indirect Treatment Comparison: Placebo-Adjusted Results From Phase 3 Trials of Two GC-C Agonists in Patients with Chronic Idiopathic Constipation - Linaclotide and Plecanatide
Gastroenterology·2017
page 1 of 6Next →

Frequent Co-authors

Jeffrey M. Johnston(11), Douglas C.A. Taylor(9), Phil Sarocco(8), David S. Reasner(7), James E. MacDougall(7), Steven J. Shiff(7), Jessica L. Abel(7), Jessica Buono(6), Joseph Menzin(6), Sheri Fehnel(6), Mark G. Currie(6), Caroline B. Kurtz(6), William Spalding(5), Hiangkiat Tan(5), Stavros Tourkodimitris(5), Bernard J. Lavins(5), Lauren Nelson(5), Carolyn Martin(5), Alyssa Goolsby Hunter(5), Harvey Schneier(5)